CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Cerenome Expects $1.55 Million in CNSide® Third Quarter Gross Billings

EarningsCNSide®Positive
AI Analysis

Summary

Cerenome reported $1.55 million in preliminary Q3 gross billings for CNSide and advanced payer coverage while planning an expanded test menu for Q4.

Financial Highlights

Revenue

$1.55 million

Importance:2/10
Sentiment:
0.30
earningsdiagnosticrevenuepayer coverageproduct expansion

Read the original article

Published by GlobeNewswire Pharma on September 30, 2026 11:30 AM

Read Original